These recordings of an August 1, 2020, LIVESTREAM event provide information on the treatment of hospitalized patients with severe or life-threatening COVID-19. Topics covered include the history and evolution of convalescent plasma therapies; implementation of the ongoing expanded access program for COVID-19 patients; current data; blood bank and donor recruitment strategies; and world perspectives on treatment of COVID-19 patients with plasma. 

 

 

August 1, 2020 LIVESTREAM Recordings
Welcome & Introduction
R.Scott Wright, M.D., Mayo Clinic, Minnesota
History of Convalescent Plasma
Arturo Casadevall, M.D., Ph.D., Johns Hopkins
Thoughts on the Design and Background of EAP from the US FDA
Peter Marks, M.D., Ph.D, Food and Drug Administration
Update on EAP – Safety Data and Enrollment
Michael J. Joyner, M.D., Mayo Clinic, Minnesota
Panel Discussion
Arturo Casadevall, M.D., Ph.D., Peter Marks, M.D., Rickey Carter, Ph.D. and Liise-anne Pirofski, M.D.
Moderators: R. Scott Wright, M.D. & C. Scott Collins, M.D.
Organization of the Team and Data, How it was Done
Jonathon (Jack) Senefeld, Ph.D., Mayo Clinic, Minnesota
Katelyn A. Bruno, Ph.D., Mayo Clinic, Florida
Blood Bank/Donor Recruitment
Camille van Buskirk, M.D., Mayo Clinic, Minnesota
Kathryn F. Larson, M.D., Mayo Clinic, Minnesota
Outcomes
Rickey E. Carter, Ph.D., Mayo Clinic, Florida
DeLisa Fairweather, Ph.D., Mayo Clinic Florida
International Perspective
Hiba Saud AlHumaidan, M.D., Sheikh Khalifa Medical City, Abu Dhabi, UAE
The Landscape of Apps and AI’s for COVID Tracking
Suraj Kapa, M.D., Mayo Clinic, Minnesota